Articles On Alcidion Group (ASX:ALC)

Title Source Codes Date
ASX Health Stocks: Immutep gets crucial therapy trial clearance; Alcidion wins $4m deal

Immutep has received regulatory clearance from the Netherlands for its Phase I clinical trial of IMP761 Alcidion nabs $4m contract in a long-term partnership with Hume Rural Health Alliance   Immutep has clearance for Phase 1 trial Immute...

Stockhead ALC 1 day ago
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

Stockhead ALC 2 weeks ago
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Stockhead ALC 1 month ago
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

Stockhead ALC 2 months ago
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

Stockhead ALC 2 months ago
Australian Broker Call *Extra* Edition – Mar 12, 2024

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

FNArena ALC 4 months ago
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Stockhead ALC 4 months ago
Market Highlights: Records tumble, Powell to testify, and 5 ASX small caps to watch today

    ASX to edge lower after Wall Street pulls back Gold and Bitcoin both touched all time highs Jerome Powell’s testimony later today US time   The ASX is poised to edge lower on Wednesday, tracking movements on Wall Street. At 8am AEDT,...

Stockhead ALC 4 months ago
FNArena Corporate Results Monitor – 05-03-2024

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALC)) – Alcidion Group ((LVH)) – LiveHire Check it out at https://www.fnarena.com/index.php/reporting_season/ Welcome to the FNArena Corporate Results Monitor: Subscrib...

FNArena ALC 4 months ago
ASX Health Stocks: Healius rips higher as new CEO takes over; Nova Eye bags record US sales

Healius has new CEO Nove Eye reports record US sales in February Cynata says first patient has been enrolled in Phase 2 trial   Healius has a new CEO, shares rip higher Healius (ASX:HLS) jumped 14% this morning after announcing that it wo...

Stockhead ALC 4 months ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead ALC 4 months ago
Australian Broker Call *Extra* Edition – Feb 09, 2024

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

FNArena ALC 5 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead ALC 8 months ago
Australian Broker Call *Extra* Edition – Nov 09, 2023

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

FNArena ALC 8 months ago
The Overnight Report: Another Day…

World Overnight SPI Overnight 6989.00 – 1.00 – 0.01% S&P ASX 200 6977.10 – 20.30 – 0.29% S&P500 4378.38 + 12.40 0.28% Nasdaq Comp 13639.86 + 121.08 0.90% DJIA 34152.60 + 56.74 0.17% S&P500 VIX 14.81 – 0.08 – 0.54%...

FNArena ALC 8 months ago
The Overnight Report: And Breathe

World Overnight SPI Overnight 6993.00 – 11.00 – 0.16% S&P ASX 200 6997.40 + 19.20 0.28% S&P500 4365.98 + 7.64 0.18% Nasdaq Comp 13518.78 + 40.50 0.30% DJIA 34095.86 + 34.54 0.10% S&P500 VIX 15.02 + 0.11 0.74% US...

FNArena ALC 8 months ago
The Fed helps support equities: Origin (ASX:ORG) bid in doubt despite improved price

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.90% to 6899.70. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify....

Rask Media ALC 8 months ago
Closing Bell: Ahead of big date with US cash rate, ASX puts October to bed with brash November debut

ASX200 climbs a very laudable +0.85%  Property stocks (+1.9%) and Health Care (+1.24%) have led the gains Small caps led by Loyalty Lithium, TG6 and Tambourah Metals   The Australian sharemarket has lifted strongly on the first day of the...

Stockhead ALC 8 months ago
Why is the Alcidion share price crashing 27% to a 52-week low?

The Alcidion Group Ltd (ASX: ALC) share price has returned from its trading halt and sunk deep into the red. At the time of writing, the healthcare technology company's shares are down 27% to a 52-week low of 7.1 cents. What's going on wit...

Motley Fool ALC 8 months ago
Atlas Arteria: Updating for the new French tax impost

Atlas Arteria's (ASX:ALC) recent share price decline reflects the material downgrade to distributions receivable by ALX from its key French toll road assets as a result of the proposed new French tax.

Morgans ALC 9 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead ALC 9 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead ALC 10 months ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead ALC 10 months ago
FNArena Corporate Results Monitor – 25-08-2023

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AX1)) - Accent Group ((A1M)) - AIC Mines ((AIZ)) - Air New Zealand ((ALC)) - Alcidion Group ((ALK)) - Alkane Resources ((APA)) - APA Group ((A1N)) - ARN Media ((AIA)) -...

FNArena ALC 10 months ago
400% organic growth in 3 years: The ASX small-cap Cyan is pumped about

Those investors with small-cap ASX shares in their portfolio have suffered greatly over the past couple of years. Since inflation rocketed, interest rates followed, and Russia stamped into Ukraine, money was pulled out from smaller player...

Motley Fool ALC 11 months ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead ALC 11 months ago
An unloved ASX stock I’m considering buying with $5,000 in August

Frustration can’t begin to describe what it’s like to own certain ASX stocks. The business is excellent — winning new customers, expanding market share — but the stock price just languishes, or even plunges. Even with a long-term horizon,...

Motley Fool ALC 11 months ago
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Stockhead ALC 11 months ago
ASX July Winners: Easing inflation, AI, and an oil rally lure sidelined traders back to risky assets

The ASX was higher by around 2.5% in July The best sectors were Tech and Energy We look at the best and worst performing ASX stocks for the month For the month of July, most major indexes on the ASX rose by around 2.5%. Name % Change...

Stockhead ALC 11 months ago
Alcidion Group (ASX:ALC) sees cashflow up 82pc for FY23

Alcidion Group (ALC) announces its Q4 FY23 results, showing strong growth in operating cash flow and new sales The company secures a renewal contract with existing customers and forms a strategic partnership to enhance patient outcomes...

themarketherald.com.au ALC 11 months ago
Alcidion share price charges 9% ahead on record quarter

The Alcidion Group Ltd (ASX: ALC) share price is on the move today as shareholders digest the company’s fourth-quarter performance. Shares in the healthcare software provider are 9.1% higher this morning, trading hands at 12 cents apiece....

Motley Fool ALC 11 months ago
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test

Clinical validation study confirms efficacy of INOVIQ’s SubB2M/CA15-3 test for breast cancer Ramsay releases several announcements this week including possible sale of joint Asian venture Mach 7 expects significant cash collections in Q4...

Stockhead ALC 1 year ago
Timing Seems Right For Alcidion Group

New research identifies Alcidion Group is attaining scale and becoming profitable at an opportune time for healthcare technology demand. -Alcidion Group’s expanded offering in a time of industry demand-Proven business model is scaling and b...

FNArena ALC 1 year ago
Australian Broker Call *Extra* Edition – Jun 21, 2023

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

FNArena ALC 1 year ago
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Stockhead ALC 1 year ago
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Stockhead ALC 1 year ago
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Stockhead ALC 1 year ago
ASX Health Stocks: Neurotech gets approval to treat children patients until they are 20 years old

Neurotech will extend its Phase 1/2 trial after ethics approval Alcidion makes further inroads into UK’s public hospitals   Neurotech to extend Phase 1/2 trial after ethics approval Paediatric neurological disorders specialist, Neurotech...

Stockhead ALC 1 year ago
Market Highlights: NY and London closed; expert warns of downside correction in US stocks

Wall Street was closed for Memorial Day, European shares were slightly down Beware of “downside correction” in the US market, expert says Rampant short-selling is putting pressure on the oil markets   Wall Street was closed for Memorial D...

Stockhead ALC 1 year ago
‘Upside surprise’: 2 small-cap ASX shares ready to break out

It remains a nerve-wracking time for investors in small-cap ASX shares. Inflation is still flying high, interest rates are still heading up, and there is still no certainty as to whether the world will avoid a recession. But, according to...

Motley Fool ALC 1 year ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead ALC 1 year ago
The Nasdaq has just entered a new bull market – is the tide also turning for ASX Tech stocks?

The tech heavy Nasdaq has officially entered a bull market How long do bulls market usually last? And what will the Nasdaq rally mean for ASX tech stocks?   Well, what do you know? Far from being in a crash-landing recession after the nea...

Stockhead ALC 1 year ago
Leading brokers name 3 ASX shares to buy today

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading brokers have named as b...

Motley Fool ALC 1 year ago
CRITERION: In a wounded tech sector, these 10 stocks are tipped for a profitable year ahead

A deep valuation rift has emerged between the larger established tech stocks and the loss-making minnows, with fears that many of the small ‘uns simply will run out of cash in a hostile fund raising climate. Of course the collapse of Silico...

Stockhead ALC 1 year ago
ASX Health Stocks: Most biotechs are still chasing maiden revenue, but here’s a few healthcare stocks with strong earnings

Alcidion increased sales significantly in the first half Cogstate sounds warning on outlook Probiotic had a super half   Most biotech firms on the ASX are clinical stage companies, meaning they are still trying to prove that their drugs a...

Stockhead ALC 1 year ago
ASX shares: Invest in these 2 stocks for a legit chance at $1 million

A $1 million portfolio might seem like a far-off dream unless you start by investing an already large sum of money. Though, picking ASX shares with the potential for returns greater than 2,000% over the long term makes this dream much more...

Motley Fool ALC 1 year ago
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Stockhead ALC 1 year ago
3 ASX All Ordinaries shares getting hammered on quarterly updates

There have been countless quarterly updates released on Monday. Some have been received well by investors, others less so. Three that haven’t gone down particularly well with investors are summarised below. Here’s why these ASX All Ord...

Motley Fool ALC 1 year ago
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Stockhead ALC 1 year ago
Alcidion (ASX:ALC) extends partnership with Leidos Australia to support healthcare services across the ADF

Alcidion (ALC) has penned an extension to its agreement with Leidos Australia for the additional delivery of a management system to support healthcare services across the Australian Defence Force (ADF)The contract extension is expected to h...

themarketherald.com.au ALC 1 year ago